InsiderFlow

Immunome, Inc.

$20.34-0.65 (-3.07%)

Prev Close

$20.99

Open

$21.23

High

$21.40

Low

$19.81

Volume

677.7K

Market Cap

$1.86B

P/E

Div Yield

Over the past 12 months, insider activity at Immunome, Inc. (IMNM) has been dominated by selling, with 10 insider purchases totaling $2.77M and 1 insider sale totaling $8.33M. The most recent insider transaction was by BIENAIME JEAN JACQUES (director), who purchased $43.7K worth of shares on Mar 12, 2026. Immunome, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.86B.

Buys (12M)

10

$2.77M

Sells (12M)

1

$8.33M

Net Activity

Net Seller

$5.56M

Active Insiders

4

last 12 mo

IMNM Price Chart

IMNM Insider Trading Activity

DateInsiderRoleTypeSharesAvg PriceValueShares After
Mar 12, 2026BIENAIME JEAN JACQUESdirectorBuy2,000$21.84$43.7K38,415
Dec 30, 2025SIEGALL CLAY BPresident and CEOBuy4,729$21.15$100.0K0
Dec 22, 2025Barchas IsaacDirectorSell383,200$21.74$8.33M0
Dec 19, 2025SIEGALL CLAY BPresident and CEOBuy7,278$20.48$149.1K0
Dec 19, 2025Tsai PhilipChief Technical OfficerBuy10,000$20.49$204.9K0
Dec 18, 2025SIEGALL CLAY BPresident and CEOBuy46,511$21.50$1000.0K0
Jun 3, 2025BIENAIME JEAN JACQUESDirectorBuy5,000$9.38$46.9K0
Mar 26, 2025SIEGALL CLAY BPresident and CEOBuy137,100$7.29$999.5K0
Mar 25, 2025BIENAIME JEAN JACQUESDirectorBuy7,800$7.78$60.7K0
Mar 24, 2025BIENAIME JEAN JACQUESDirectorBuy7,000$8.21$57.5K0
Mar 24, 2025Tsai PhilipChief Technology OfficerBuy12,300$8.42$103.6K0

IMNM Insider Buying Activity

The following table shows recent insider purchases of Immunome, Inc. (IMNM) stock reported via SEC Form 4 filings.

DateInsiderRoleTypeSharesAvg PriceValueShares After
Mar 12, 2026BIENAIME JEAN JACQUESdirectorBuy2,000$21.84$43.7K38,415
Dec 30, 2025SIEGALL CLAY BPresident and CEOBuy4,729$21.15$100.0K0
Dec 19, 2025SIEGALL CLAY BPresident and CEOBuy7,278$20.48$149.1K0
Dec 19, 2025Tsai PhilipChief Technical OfficerBuy10,000$20.49$204.9K0
Dec 18, 2025SIEGALL CLAY BPresident and CEOBuy46,511$21.50$1000.0K0
Jun 3, 2025BIENAIME JEAN JACQUESDirectorBuy5,000$9.38$46.9K0
Mar 26, 2025SIEGALL CLAY BPresident and CEOBuy137,100$7.29$999.5K0
Mar 25, 2025BIENAIME JEAN JACQUESDirectorBuy7,800$7.78$60.7K0
Mar 24, 2025BIENAIME JEAN JACQUESDirectorBuy7,000$8.21$57.5K0
Mar 24, 2025Tsai PhilipChief Technology OfficerBuy12,300$8.42$103.6K0

IMNM Insider Selling Activity

The following table shows recent insider sales of Immunome, Inc. (IMNM) stock reported via SEC Form 4 filings.

DateInsiderRoleTypeSharesAvg PriceValueShares After
Dec 22, 2025Barchas IsaacDirectorSell383,200$21.74$8.33M0

IMNM Insiders

BIENAIME JEAN JACQUES

director

Bought $43.7K
2 tradesLast: Mar 11, 2026
SIEGALL CLAY B

President and CEO

Bought $2.25M
4 tradesLast: Dec 30, 2025
Barchas Isaac

Director

Sold $8.33M
2 tradesLast: Dec 22, 2025
Tsai Philip

Chief Technical Officer

Bought $204.9K
1 tradesLast: Dec 19, 2025
BIENAIME JEAN JACQUES

Director

Bought $165.1K
3 tradesLast: Jun 3, 2025
Tsai Philip

Chief Technology Officer

Bought $103.6K
1 tradesLast: Mar 24, 2025